深圳市海王生物工程股份有限公司 关于股票交易异常波动的公告

Group 1 - The company's stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices over two consecutive trading days from November 26 to November 27, 2025 [2] - The company has verified that there are no corrections or supplements needed for previously disclosed information [3] - There have been no significant changes in the company's production and operational conditions, and no undisclosed major matters related to the company have been identified [5] Group 2 - The company confirmed that there are no undisclosed significant matters that should be disclosed according to the Shenzhen Stock Exchange's listing rules [7] - The company and its major shareholders did not engage in buying or selling the company's stock during the period of abnormal fluctuation [5] - The company has ensured compliance with fair information disclosure regulations [6]